Why LENSAR, Inc.’s (LNSR) Stock Is Down 5.47%
As of Monday, July 06, LENSAR, Inc.’s LNSR share price has dipped by 5.47%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Commentary & Analysis
Why LENSAR, Inc.’s (LNSR) Stock Is Up 7.77%
As of Wednesday, June 24, LENSAR, Inc.’s LNSR share price has surged by 7.77%, which has investors questioning if this is right time to sell.Michael Rose
Why LENSAR, Inc.’s (LNSR) Stock Is Down 5.75%
As of Thursday, June 18, LENSAR, Inc.’s LNSR share price has dipped by 5.75%, which has investors questioning if this is right time to buy.Jenna Brashear
Why LENSAR, Inc.’s (LNSR) Stock Is Up 5.67%
As of Monday, May 11, LENSAR, Inc.’s LNSR share price has surged by 5.67%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why LENSAR, Inc.’s (LNSR) Stock Is Up 12.05%
As of Friday, May 08, LENSAR, Inc.’s LNSR share price has surged by 12.05%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $61.5 | $337.2 | 18% |
|
| Shares Out (Mil) | 15.4 | 41.9 | 26% |
|
| Institutional Ownership | 66.5% | 77.8% | 41% |
|
| Float (Mil) | 8.8 | 34.7 | 18% |
|
| Beta | 0.87 | 0.85 | 51% |
|
| Avg Daily Volume (000s) | 41 | 278 | 26% |
|
| Price Change (52-week) |
(62.2%) | 58.7% | 11% |
|
| Growth | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.2% | 11.8% | 77% |
|
| Net Income (5yr) | (11.6%) | (5.8%) | 27% |
|
| EPS (5yr) | 7.7% | 11.4% | 42 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.3%) | (16.3%) | 50% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.220) | $1.870 | ($0.720) | |
| Month Ago EPS | ($0.220) | $1.870 | ($0.720) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($0.270) | ($0.080) | ($0.710) | |
| Year/Year Chg | (109.3%) | (165.2%) | (118.8%) | |
| Financials | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $58 | $152 | 21% |
|
| Net Income (TTM) (Mil) | $29 | ($10) | 52% |
|
| EPS (TTM) | $2.439 | ($0.500) | 75% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | ($2) | 18% |
|
| Net Cash Flow (TTM) (Mil) | ($7) | $1 | 32% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $22 | 20% |
|
| Enterprise Value (Q1) (Mil) | $74 | $304 | 19% |
|
| Valuation | LNSR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.63 | 2.80 | 81% |
|
| P/E | 2.2 | 31.1 | 2% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.3 | 1.9 | 12% |
|
| Ratios | LNSR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 45.7% | 59.1% | 57% |
|
| Net Margin | 50.9% | (7.3%) | 97% |
|
| ROA | 42.2% | (13.7%) | 99% |
|
| ROE | (518.0%) | (15.8%) | 1% |
|
| Liabilities to Assets | 62.9% | 44.7% | 57% |
|
| F-Score | 5 | 4 | 51% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Magic Formula Screen
Factors: Value, Quality
Joel Greenblatt's investing approach is based on finding companies with high return on investment that are trading for less than they are worth.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
